Baclofen and Nulytely drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baclofen (baclofen) and Nulytely (polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride). Common drug interactions include pain among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Baclofen and Nulytely. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Nulytely?

Nulytely has active ingredients of polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. eHealthMe is studying from 1,377 Nulytely users. Check the latest studies of Nulytely.



On Jul, 24, 2026

22 people who take Baclofen and Nulytely together, and have interactions are studied.

Baclofen and Nulytely drug interactions.

What are the common drug interactions of Baclofen and Nulytely, by gender? *:

female:

  1. Pain
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Abasia (inability to walk)
  4. Blindness
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Dysstasia (difficulty in standing)
  7. Eye movement disorder
  8. Joint swelling
  9. Nausea (feeling of having an urge to vomit)
  10. Oedema peripheral (superficial swelling)

male:

  1. White blood cell count decreased
  2. Bone marrow failure
  3. Drug level below therapeutic
  4. Fall
  5. Femur fracture
  6. Fibula fracture
  7. Fracture delayed union (delayed cure of broken bone)
  8. Fracture displacement
  9. Haematochezia (passage of stools containing blood)
  10. Joint swelling

What are the common drug interactions of Baclofen and Nulytely, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Withdrawal hypertension (low blood pressure due to nicotine withdrawal)

20-29:

  1. Bone marrow failure
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Melaena (the passage of black, tarry stools)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. White blood cell count decreased

30-39:

  1. Lymphocyte count decreased
  2. White blood cell count decreased
  3. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  4. Drug level below therapeutic
  5. Neutropenia (an abnormally low number of neutrophils)

40-49:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Ataxia (loss of full control of bodily movements)
  5. Back pain
  6. Candidiasis (candidiasis or thrush is a fungal infection)
  7. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)
  8. Colitis (inflammation of colon)
  9. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  10. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Chronic kidney disease
  2. Comminuted fracture (bone has broken into several pieces)
  3. Fall
  4. Femur fracture
  5. Fibula fracture
  6. Fracture delayed union (delayed cure of broken bone)
  7. Fracture displacement
  8. Joint swelling
  9. Loss of consciousness
  10. Muscle atrophy (a decrease in the mass of the muscle)

60+:

  1. Abasia (inability to walk)
  2. Blindness
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Haematochezia (passage of stools containing blood)
  5. Pneumonia
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  8. Dysstasia (difficulty in standing)
  9. Eye movement disorder
  10. Joint swelling

What are the existing conditions these people have? *

  1. Pain: 5 people, 22.73%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 18.18%
  3. Constipation: 4 people, 18.18%
  4. Irritable Bowel Syndrome: 3 people, 13.64%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 13.64%
  6. Osteoporosis (bones weak and more likely to break): 3 people, 13.64%
  7. Intervertebral Discitis (infection in the intervertebral disc space): 3 people, 13.64%
  8. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 9.09%
  9. Dry Mouth: 2 people, 9.09%
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and Nulytely?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Baclofen and Nulytely:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Baclofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nulytely:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Baclofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nulytely and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on baclofen and polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride (the active ingredients of Baclofen and Nulytely, respectively), and Baclofen and Nulytely (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: